Millennium Management’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,800
Closed -$102K 7879
2021
Q3
$102K Sell
21,800
-6,712
-24% -$32.9K ﹤0.01% 6431
2021
Q2
$152K Buy
+28,512
New +$149K ﹤0.01% 6117
2020
Q3
Sell
-70,112
Closed -$217K 5066
2020
Q2
$217K Buy
70,112
+19,522
+39% +$56.7K ﹤0.01% 3817
2020
Q1
$161K Sell
50,590
-40,397
-44% -$177K ﹤0.01% 3460
2019
Q4
$455K Sell
90,987
-63,440
-41% -$303K ﹤0.01% 3443
2019
Q3
$747K Buy
154,427
+135,580
+719% +$711K ﹤0.01% 3029
2019
Q2
$109K Sell
18,847
-11,099
-37% -$73.2K ﹤0.01% 3879
2019
Q1
$210K Buy
+29,946
New +$198K ﹤0.01% 3715
2018
Q4
Sell
-86,047
Closed -$601K 4505
2018
Q3
$601K Sell
86,047
-67,108
-44% -$504K ﹤0.01% 3139
2018
Q2
$1.45M Sell
153,155
-11,626
-7% -$111K ﹤0.01% 2620
2018
Q1
$1.68M Buy
164,781
+54,406
+49% +$556K ﹤0.01% 2417
2017
Q4
$1.1M Sell
110,375
-14,156
-11% -$155K ﹤0.01% 2647
2017
Q3
$1.39M Buy
+124,531
New +$1.46M ﹤0.01% 2353
2015
Q3
Sell
-100,000
Closed -$616K 3912
2015
Q2
$616K Buy
+100,000
New +$614K ﹤0.01% 2523

Other funds holding CO

Millennium Management's CO Position: Q4 2021 in Review

Millennium Management sold out of Global Cord Blood Corporation (CO) in Q4 2021, closing a stake of 21,800 shares — an estimated $102K sold.

Millennium Management first reported a position in CO in Q2 2015 and held it in 14 quarters. The position peaked at $1.68M in Q1 2018. 28 funds tracked by Wall St. Rank hold CO as of Q4 2021.

  • Millennium Management reported no remaining Global Cord Blood Corporation position as of Q4 2021 after selling out during the quarter.
  • Millennium Management sold 21,800 Global Cord Blood Corporation shares in Q4 2021, an estimated $102K.
  • Millennium Management first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 14 quarters.
  • Millennium Management's Global Cord Blood Corporation position peaked at $1.68M in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.